Category Archives: Healthcare Solutions

Multispectral Optoacoustic Tomography (MSOT) can now more reliably detect early stages of inflammation

GERMANY, Mar-30-2017 — /EPR HEALTHCARE NEWS/ — Ulcerative colitis and Crohn’s disease are the most common inflammatory bowel diseases (IBD). Globally, more than 4 million people suffer from recurring inflammation of the intestinal mucosa. To date, non-invasive methods have not been able to detect these forms of IBD reliably. Researchers at the University Hospital Erlangen (Germany) have now shown for the first time how Multispectral Optoacoustic Tomography (MSOT) can more reliably detect early stages of inflammation when compared with other non-invasive diagnostic methods. These results have recently been published in the New England Journal of Medicine.

Evaluating the inflammatory activity of the intestines early and accurately helps to prevent complications associated with IBD and guide an optimal therapy regime. Currently, doctors frequently rely on an invasive endoscopy procedure to assess the intestinal mucosa of patients with IBD. Additionally, non-invasive imaging methods are increasingly used in the clinic. For example, ultrasound allows clinicians to examine the structure, thickness and blood perfusion of the intestinal wall with changes in perfusion patterns indicating an onset of inflammation.

“With the MSOT procedure, we additionally use laser light, by which we can detect inflammation earlier than previously possible with ultrasound”, explains Prof. Dr. Maximilian Waldner, Professor at the University Hospital Erlangen. “The earlier we detect signs of an upcoming flare – i.e., a change in blood content – the quicker we can react and start a preventive treatment”. The MSOT technology was developed by iThera Medical in Munich, and was first used on IBD patients last year.

The researchers of the University Hospital Erlangen have recently published their results in the renowned New England Journal of Medicine. “We examined 108 patients with Crohn’s disease using the MSOT technology and compared the results to established non-invasive diagnostic procedures as well as endoscopy and histology”, says Prof. Waldner. “We were able to demonstrate that hemoglobin values in the tissue measured with MSOT indicate very accurately the inflammatory activity in the intestines. The method appears to be superior to other non-invasive procedures, as MSOT for the first time was able to detect even low levels of inflammation without having to perform endoscopy”.

Dr. Ferdinand Knieling, a physician at the University Hospital Erlangen, adds: “We are hoping that this principle can be applied to many applications and, in particular, also be used to enable safe evaluations of children and adolescents. With this new examination method, many of the currently invasive procedures might become obsolete.”

In optoacoustic imaging, the physician scans the intestines transabdominally through the skin, applying pulsed laser light in the near-infrared region. The energy of the light absorbed in tissue is converted into acoustic signals which are then acquired by an ultrasound detector. Christian Wiest, CEO of iThera Medical, comments: “MSOT is a new diagnostic imaging modality that can detect changes in tissue composition associated with a variety of diseases, without the use of contrast agents. The technology has already been applied in other clinical feasibility studies, e.g. for the detection of melanoma metastasis in sentinel lymph nodes or for the assessment of suspicious breast lesions”.

The results of the IBD study at the University Hospital Erlangen were published on March 30th 2017 in the New England Journal of Medicine (Volume 376, Issue 13, pg.1292-1294).

SOURCE: EuropaWire

Startup mentored by Promwad created one of the best IoT products in Europe

Vilnius/Lithuania, 2016-Oct-18 — /EPR Healthcare News/ — ZIVE smart radiation monitor has reached the final of Elektra Awards 2016, a big influential contest for the electronics market players. This device designed by R-NOX startup with the assistance of Promwad Electronics Design House was named one of six best innovative products of Europe exploiting the Internet of Things potentialities.

ZIVE is a portable radiation monitor of the next generation that can connect to smartphones and tablets via Bluetooth. It’s the first device of professional level designed for common people. It has a user-friendly interface, a Geiger-Muller counter, and a low market price comparing with other high-precision radiation monitors.

promwad-mobile_zive

ZIVE radiation monitor measures gamma rays, ionizing radiation, and X-rays. Differentiating features of the device:

  • Calibrated by accredited European laboratories (CE).
  • High accuracy at a lower price in comparison with other similar devices.
  • “Smart monitor” mode that provides users with specific health and well-being advice: how to interpret the measurements and reduce the risks.
  • Working with maps to create eco-routes: save radiation spots, find cleaner routes.

The collected ZIVE data is used for the real-time global map of radiation contamination.

Roman Pakholkov, Promwad’s CEO and R-NOX’s mentor, says that the data collected by ZIVE users is stored in the eco-platform, which is becoming the most detailed in the world. This platform allows accelerating the innovations development for the environmental management and can be integrated into other devices and applications via the open API.

To date, R-NOX has developed partnerships with the largest tour operator in the Chernobyl Nuclear Power Plant Zone of Alienation; Greenpeace; companies and organizations in Japan, Finland, Singapore, and other countries.

Promwad continues its work in supporting new electronics design projects in the IoT field. The company believes in the high potential of this popular trend and are ready to share their experience in the development and manufacture of electronic products for the global consumer electronics market.

The best companies of Elektra Awards 2016 will be announced on Thursday, 1st December, at the awards ceremony taking place in The Ballroom, Grosvenor House Hotel, London.

Contact-Details:
promwad-logo
Promwad

Olga Potonya
olga.potonya@promwad.com
+370 (5) 214 12 44 ex.227

Via EPR Network
More Healthcare press releases

Global leader in serialization solutions Systech to attend the annual pharmaceutical congress CPhI Worldwide in Barcelona, 4 – 6 Oct 2016

systech_international_slogo_europawireBRUSSELS, 28-Sep-2016 — /EuropaWire/ — Systech International, a global leader in brand protection technologies, will partner with Sharp Packaging and SINEL SYSTEMS, part of the Autajon Group, at CPhI Worldwide, the annual pharmaceutical congress held in Barcelona from 4 – 6 October 2016.

Systech will be part of Sharp’s panel discussion addressing delegates on the theme of “Serialization: Optimizing Your Supply Chain Means Optimizing Your Partners.” The presentation will explore the critical path to supply chain readiness, risk assessment, benchmarking and serialization risk mitigation options. The briefing will take place in the Pharma Insight Briefing room on Tuesday, 4 October 2016 at 11:30am CEST.

Systech will also showcase its UniSeries™ serialization software offered as an integrated solution within Autajon’s exhibit booth #2P16 (Hall 2).

CPhI Worldwide, together with co-located events ICSE, InnoPack, P-MEC and FDF, will host more than 36,000 visiting pharma professionals from 4-6 October at the Fira Gran Via, Barcelona, Spain. More than 2,500 exhibitors from 150+ countries gather at the event to network and take advantage of more than 100 free industry seminars. Every sector of the pharmaceutical market is represented under one roof, this year in a new location in Barcelona.

With thousands of implementations across the globe, Systech is the world’s most trusted brand protection expert, and its UniSeries offering is the industry standard for serializing products. UniSeries is offered as an integrated solution with both Sharp Packaging and Autajon Group’s hardware. Systech’s patented, configurable software offers manufacturers the flexibility to adapt to new regulations without extensive reworking or revalidation, thereby reducing implementation, training and support costs.

“We are recognized as the world leader in serialization and brand protection,” states Manfred Voglmaier, Senior Director Sales Europe, Systech International. “With more than 30 years of experience in providing highly configurable solutions for serialization across a variety of industries ― along with our partners Sharp Packaging and Sinel ― gives us a unique insight for this panel.”

Systech’s products are in greater demand than ever before since it is estimated that over 15,000 production lines for prescription medication in Europe must be fitted with a serialization system over the next three years. The European Commission adopted a regulation on October 2, 2015, under which the serialization of prescription medicine packages will become mandatory in all EU countries by 2019.

Show exhibit hours are on Tuesday, 4 October – Thursday, 6 October. Systech representatives will be available in the Sharp Packaging booth #3L56 (Hall 3) during the event, as well as in the Autajon booth #2P16 (Hall 2). They will showcase Systech’s software solutions on sample packaging lines and via live demos throughout the event.

SOURCE: EuropaWire

Finnish Servicepoint to resell, install and support Systech’s serialization solutions in Scandinavia, the Baltic States, and Russia

servicepoint-fi__logo_europawireFinland, 23-Sep-2016 — /EPR HEALTHCARE NEWS/ — Systech International, a global leader in brand protection technologies, today announces the extension of its strategic partnership with Servicepoint, a leading serialization automation supplier.

Systech has signed a global agreement with Servicepoint, allowing the company to act as a single point of contact for customers across Europe. Through this agreement, Servicepoint will now resell, install and support Systech’s serialization solutions to customers of any size across Europe, especially in Scandinavia, the Baltic States, and Russia.

This agreement comes at a critical time within the pharmaceutical industry, as the European market is growing exponentially. It is estimated that over the next three years, 15,000 production lines for prescription medication in Europe must be fitted with a serialization system. The European Commission adopted a regulation on October 2, 2015, under which the serialization of prescription medicine packages will become mandatory in all EU countries by 2019.

Systech and Servicepoint first engaged two years ago when jointly delivering serialization and automation/integration solutions to a pharmaceutical manufacturing client. As a result, both companies were able to offer enhanced solutions and increase their speed of delivery.

Servicepoint maintains and offers professional services, automation services, retrofit/upgrade services to Systech customers and provides Level 1 and 2 support, while Systech provides Level 3 support for the software.

“Servicepoint has a solid network of over 50 professionals in Europe, which, when combined with Systech’s growing regional support, creates a large and experienced talent pool for the delivery of serialization initiatives,” states Harry Saint-Preux, Director, Global Alliances & Channels, Systech International.

“Servicepoint has extensive expertise and a long history automating hundreds of production lines for different fields of industry and European pharmaceutical manufacturers, as well as experience with track-and-trace initiatives. Systech and Servicepoint’s combined approach provides manufacturers with the solutions, services and support required to address Europe’s challenging serialization requirements,” notes Saint-Preux.

Risto Finne, chairman of the board, Servicepoint, comments, “Servicepoint is honored to enter into this partner agreement with Systech, who we consider to be the global market leader in serialization. This cooperative paves the way for numerous new business opportunities, particularly with Russian companies that need to rapidly employ serialization. Our experience in integrating modifications and upgrades of existing production lines, in addition to new, turnkey, fully-automated solutions for the serialization and packing of medical, food and other sensitive products puts us in an enviable market position.”

Servicepoint is one of only a handful of suppliers in the European market that provides an all-inclusive production automation solution including planning, installation, testing, and maintenance.

SOURCE: EuropaWire

Sway Medical’s app for sports concussion exam received European CE Mark as Medical Device

sway-concussiontest-is-a-validated-ios-app-based-concussion-management-system

TULSA, OK, 08-Sep-2016 — /EPR HEALTHCARE NEWS/ — Sway Medical is a US medical device company who’s software turns an iPhone or iPad into a mobile medical device that provides immediate medical grade, objective concussion measurement to medical professionals.

Sway Medical LLC (Sway) would like to announce its official availability in all European Union Countries. Sway was issued its CE Mark after being marketed in the United States and Canada for two years. This is significant because European sports organizations ranging from youth through pro level now have an affordable and convenient sideline assessment tool supporting concussion related medical decision making. Medical professionals and trained coaches can obtain a concussion assessment via an Apple mobile device (iPhone or iPad) and the Sway Balance™ System web-portal. Acute objective measurements are obtained by performing a 1.5 minute balance and reaction time test protocol. Licensed athletic trainers, physical therapists and athletic therapists are able to join physicians in acutely managing the underserved market of youth sports, ages six and older.

Concussion injuries are very common in sports, often going un-reported or ignored until the obvious symptoms have incapacitated the athlete or draws the attention of a parent or coach. Second Impact Syndrome (SIS) is a serious medical condition with published mortality rates of up to 50%. SIS occurs when an athlete returns to play while still recovering from an initial concussion injury. During this time, the brain is highly susceptible to additional injury and complications. The Sway Balance™ System is able to accurately assess and track the acute and chronic outcome related to an athlete’s balance, motion reaction time and concussion symptoms. The Sway Balance™ System provides a graphical representation comparing suspicious injury event tests against a pre-injury “normative” or baseline score. The comparison of event tests against an established baseline is a common measurement for traumatic brain injury diagnosis and recovery tracking.

The Sway Balance™ System is available for purchase by licensed medical professionals involved in school, occupational or sports medicine through www.swaymedical.com. Additional protocols are available to assess an individual’s “Fall Risk” or “Functional Status”.

SOURCE: EuropaWire

GenQual and R-Pharm collaborate to deliver predictive diagnostics for novel anti-IL-6 antibody for autoimmune diseases

Seattle, WA, San Francisco, CA and Moscow, Russia, 2016-May-25 — /EPR Healthcare News/ — R-Pharm and GenQual are pleased to announce a new collaboration focused on the development of novel predictive diagnostic tools in the area of Rheumatoid Arthritis and Autoimmune diseases.

The GenQual proprietary real-time PCR platform, when applied to the genes that are involved in the manifestation of several autoimmune diseases, allows us to detect and assess single nucleotide polymorphisms. Here, allelic determination is used as potential predictor of the treatment response by the novel anti-IL6 antibody, which is currently in development by R-Pharm.

GenQual Founder and CEO Jonathan Mirich said, “This partnership is exciting for GenQual as we advance in our goal to deliver predictive diagnostic tools for the treatment of autoimmune disorders. We are very excited about the possibilities in this space and are thankful to have quality partners in R-Pharm.”

R-Pharm CEO Vasily Ignatiev indicated the importance of the Autoimmune diseases as an area of the development and growth for R-Pharm, as well as the development of novel diagnostic tools aimed to increase the level of predictive response and efficiency of the upcoming treatment paradigm.

About GenQual
GenQual develops proprietary biomarker diagnostics for autoimmune and oncology indications.  Our personalized medicine products are designed to facilitate early disease detection and diagnosis, and to improve treatment approaches at the molecular level.  GenQual is a privately-held corporation based in Seattle, WA area, USA.

About R-Pharm
R-Pharm is a private Russian pharmaceutical company founded in 2001. It employs over 3,500 highly qualified specialists in 60+ branches. R-Pharm operates in Russia and CIS, USA, Germany, Japan, Turkey/MENA.

The company is involved in R&D, manufacturing (finished dosage forms, biotech and chemical APIs), marketing, sales and distribution of innovative pharmaceutical products in hospital/specialty care therapeutic areas.

R-Pharm collaborates with major international pharmaceutical companies and universities in the fields of drug discovery, development, clinical trials, manufacturing and commercialization.  The company operates several  GMP compliant manufacturing sites in Russia and Germany, research, BD/licensing and marketing affiliates in Japan, Germany, Turkey and US.

Marketed portfolio and pipeline features drugs used in oncology, hematology, autoimmune diseases, HIV, HCV, neurology, diabetes, cardiology, as well as antibiotics, contrast media and anesthesia agents.

Contact

R-Pharm
info@rpharm.ru
www.r-pharm.com/en/

 

GenQual

info@genqual.com
206.659.7825
www.genqual.com

 

Via EPR Network
More Healthcare press releases

HTN propone EASY BLOOD PRESSURE, una nuova e facile soluzione per il monitoraggio domiciliare della #pressionearteriosa

Brescia, Italia, May 19, 2015 — /EPR NETWORK/ — Secondo la #SIIA (Società Italiana dell’Ipertensione Arteriosa), in Italia


• il 31% delle donne ed il 33% degli uomini soffre d’ipertensione arteriosa*
• il 14% delle donne ed il 19% degli uomini “sani” sono in una condizione di rischio**
• solo il 35% degli ipertesi trattati ha valori di pressione arteriosa normalizzati”***
• l’obbiettivo è portare, entro il 2015, il 70% della popolazione degli ipertesi alla normalizzazione dei valori di pressione arteriosa.

* Ipertesi: sono i pazienti con pressione arteriosa uguale o superiore a 140/90 mmHg..
** Condizione di rischio: quando il valore della pressione sistolica è compreso fra 140 e 160 mmHg e quello della diastolica è compreso fra 90 e 95 mmHg.
*** Secondo le Linee Guida Europee 2013 i valori di norma sono quelli inferiori a 130/85..

Le Linee Guida 2013 della Società Europea dell’#Ipertensione sottolineano che i valori di pressione arteriosa rilevati al domicilio hanno un significato prognostico maggiormente predittivo di accidenti cardiovascolari rispetto ai valori rilevati in ambulatorio.
#HTN Easy Blood Pressure è l’abbonamento annuale per il monitoraggio della pressione arteriosa, in modo semplice ed efficace.

Il servizio si basa sull’utilizzo, in alternativa, di due device per la rilevazione dei valori della pressione arteriosa:
• iHealth BP5, a trasmissione via Bluetooth
• A&D UA-767NFC, a trasmissione via NFC
L’abbonato è in grado di rilevare quante misure desidera e tutte saranno trasmesse, attraverso uno smartphone, al proprio Personal Health Record, sempre accessibile in modo sicuro, attraverso la piattaforma software proprietaria #SmartTelemedicine.
Ogni tre mesi, oppure a sua richiesta, riceverà un referto sui valori registrati.

In sintesi, l’offerta prevede:
• quattro prestazioni di refertazione specialistica dei valori pressori all’anno
• una chiamata a personale sanitario HTN all’anno
• fino a 4 Personal Health Record sulla piattaforma software SmartTelemedicine
• il comodato d’uso gratuito dell’apparecchiatura #iHealth BP5 ovvero A&D UA-767NFC
Ulteriori prestazioni di refertazione e/o teleconsulto possono essere richieste in qualsiasi momento.

Per maggiori informazioni: http://www.e-htn.it/it/contatti/

Contact-Details: Dr. Fulvio Glisenti – Presidente, Health Telematic Network s.r.l.
info@e-htn.it

Via EPR Network
More Healthcare press releases

Regenexx Announces the Publication of “Orthopedics 2.0 – How Regenerative Medicine and Interventional Orthopedics will Change Everything” on Amazon Kindle

Broomfield, CO, February 02, 2015 — /EPR HEALTHCARE NEWS/ — With more than 40,000 downloads, “Orthopedics 2.0 – How Regenerative Medicine and Interventional Orthopedics will Change Everything” is now available on Amazon Kindle. The third edition of the top-selling e-book is being offered as a free download through Jan. 6, 2015.

Written by Dr. Chris Centeno, this e-book delves into the human musculoskeletal system and explains how everything works together in concert to maintain our physical wellbeing. When a single component in this chain is damaged, it can lead to a cascade of joint, spine and connective tissue problems, resulting in chronic pain.

Using the Regenexx SANS approach, Orthopedics 2.0 walks you through a series of tests and exercises that you can do on your own to better understand where your own body is struggling to maintain proper stability and alignment, explaining the possible reasons and long term implications along the way. Orthopedics 2.0 also explores how Regenexx is pioneering the new field of Interventional Orthopedics, where the use of regenerative biologic treatments, such as adult stem cell therapy and platelet rich plasma, are being used to help repair and strengthen damaged tissues, as opposed to invasive surgeries that often remove important tissues when a joint or the spine becomes damaged.

With hyperlinks to more detailed information, related studies and commentary, this book condenses a vast amount of data and resources into an enjoyable and entertaining read.

About Regenexx
Since its genesis in 2005, Regenexx has been a world-leader in the use of adult stem cell treatments for orthopedic conditions, providing non-surgical, biologic therapies delivered with high accuracy through a needle. Regenexx has collected and published more data on stem cell patients than any other company and are dedicated to reinventing orthopedic care to help patients avoid invasive surgery.

Featured on television and media outlets such as the Doctors TV show, ABC News, Good Morning America and many others, Regenexx is taking orthopedic stem cell therapy to an exciting new level.

For more information about this e-book or to talk with a Regenexx Liaison, please call 888-525-3005 or email info@regenexx.com. Visit Regenexx online at:http://www.regenexx.com/

Contact-Details: Regenexx
Contact: Mark Testa
403 Summit Blvd., Suite 201
Broomfield, CO 80021
Phone: 888.525.3005
Email: info@regenexx.com
Web – http://www.regenexx.com/

Via EPR Network
More Healthcare press releases

ViroCarb’s anti HIV Crowd Funding Campaign

Toronto, Canada, December 01, 2014 — /EPR HEALTHCARE NEWS/ — ViroCarb Inc. has launched a worldwide crowd funding campaign to promote the development of its new HIV infection inhibitor.

WORLD AIDS DAY – Make a donation to save lives from AIDS! Support new treatment development at: https://www.indiegogo.com/projects/funding-a-new-therapy-against-drug-resistant-hiv/x/9240077

Despite the great progress made in HIV/AIDS treatment, there is still an urgent need for new drugs, particularly for people who have had to abandon existing treatments due to HIV drug resistance and side effects.

The current treatment of HIV/AIDS involves the use of three or more drugs from five main general classes, used in combination. While this antiretroviral therapy (ART) has helped to reduced morbidity and mortality from AIDS, long term toxicity and the emergence and transmission of drug resistant HIV strains limit the effectiveness. Thus, despite therapy which can render this a chronic, rather than acute fatal infection, development of new drugs to prevent infection and overcome drug resistant strains, is increasingly urgent.

ViroCarb Inc. is developing a novel technology that addresses infections by drug resistant HIV strains. Developed from the identification of a new, natural resistance factor against HIV infection by scientists at SickKids and Canadian Blood Services, ViroCarb’s inhibitor works against a previously overlooked target on the virus to block HIV from entering human cells, the very first step in the infection. It works against all HIV strains.

Funds are needed to aid in moving forward to support preclinical studies; therefore ViroCarb Inc. has started an international crown funding campaign to carry out these HIV model studies needed before conducting clinical trials.
Please support this new way to block HIV.

Contact-Details: Dr. Mario Huesca
479 Simonston Boulevard.
Thornhill ON.
L3T 4M4 Canada

Facebook: https://www.facebook.com/ViroCarb;
Website: http://www.virocarb.com

 

Via EPR Network
More Healthcare press releases

Hays PureWater Launches $10,000 Campaign To Save Lives

WASHINGTON, IA, November 25, 2014 — /EPR HEALTHCARE NEWS/ — 783 million people live each day without clean water and 3.4 million die annually from a lack of pure water. To combat these staggering statistics, Washington-based nonprofit, Hays PureWater, launched a crowd-funding campaign. The money raised will fund 30 Khlor Glen technology units to purify water for 150,000 individuals. The organization hopes to raise $10,000 by December 1st.

Hosted on crowd-funding platform IndieGoGo, the project offers nine sponsorship levels. Each level includes novelty “rewards” for donors, ranging from stickers to t-shirts to a trip to Haiti. The rewards are unique, innovative and hands on, giving donors a sense of ownership in the project. For just $2,500, an investor can travel to Haiti (all inclusive) to see the life changing benefits first hand.

The Khlor Glen is a simple unit that turns salt water into chlorine. The chlorine treats infected water, removing deadly impurities and toxins in just one hour. It’s solar powered and easily used in remote areas, where clean water is most needed. “It will also impact malaria zones as it can be used as a bug repellant and protect from disease,” says founder John Hays. “Even just using the chlorine produced by the unit as a sanitizer can cut down on so many infections that the natives in these areas don’t even know exist.”

In the last eight years, Hays PureWater distributed over 4,000 purifying units around the world, changing entire communities by implementing this system. It’s proven to work. Hays builds each system with the help of a dedicated group of volunteers. Nothing is outsourced, ensuring the most effective product for the lowest cost. Now all they need is help from their community to change the lives of those in need once more.

See the crowd-funding campaign here: https://www.indiegogo.com/projects/hays-purewater-providing-clean-water-globally

ABOUT Hays PureWater
In 2006, after traveling around developing nations on missions trips, John Hays began to create a low cost, portable solution for water purification. John, who worked with municipal water works for over 30 years, put his experience to use and developed the Khlor Gen system. Through the years, the design and look has been changed and improved, but the mission has stayed the same. The organization exists to provide people with clean water, reaching out to them through word and deed. Eight years and 4,000 units later, that mission continues full steam ahead. For more information, logon to www.hayspurewater.com.

###

Contact-Details: TJ Widbin
tj@hayspurewater.com
319-470-7391

Via EPR Network
More Healthcare press releases

Health Gorilla Releases Mobile Application for Doctors

Digital Health Leader Expands Marketplace Access with Mobility

SUNNYVALE, CA., 2014-8-20 — /EPR Healthcare News/ — Health Gorilla™, Inc., the first online healthcare marketplace to connect doctors and clinicians with over 9,000+ diagnostic labs and 35,000+ radiology centers, has announced today the release of Health Gorilla mobile.  Health Gorilla mobile provides access to the Health Gorilla Marketplace through the Apple® iPhone® and iPad™.

Today over 68% of doctors have standardized on the Apple platform to communicate with peers and patients. Doctors can now use their mobile devices to place electronic orders with Health Gorilla mobile to diagnostic labs, radiology centers, physical therapy, skilled nursing facilities (SNFs) and durable medical equipment (DME) and other medical providers nationwide with the ability to track and review the results instantly as they arrive.  Physicians can then forward electronic results within their practice or exchange them with peers and patients to streamline the process and improve quality of care.

According to a study published by the New England Journal of Medicine noted that approximately 59.3% of all of a primary care physician’s daily emails were for the interpretation of test results and 21.7% were responses to patients.  The use of email generally increases the risk for doctors and their patients as most email services are not HIPAA compliant.

Another study published in the Journal of the American Medical Association (JAMA) reported that researchers from the Michael E. DeBakey Veterans Affairs Medical Center in Houston conducted a survey of primary care practitioners and found that a third reported missing alerts about test results from an electronic health record notification system designed to inform them when a patient has abnormal test results.

Doctors are adopting iPad and iPhones as the platform of choice to communicate with peers and patients. Health Gorilla mobile integrated messaging greatly reduces the risk in communication between a doctor and their patients by offering a fully HIPAA compliant environment. Health Gorilla mobile enables a physician to securely and compliantly forward diagnostic test results, radiology images, admission and discharge summaries and other clinical documents to patients and care coordinators through secure messaging.

Benefits of Health Gorilla Mobile Include:

  • HIPAA compliant and ONC modular certified MU2 solution
  • Order in less time than it takes to use fax forms
  • Receive results faster wherever you are
  • Forward results to patients instantly
  • Immediately refer results to another doctor and send messages
  • Eliminate error prone paper processes
  • Mobile solution available at no charge for doctors and their teams

“We believe that the value proposition is clear and compelling for doctors and their teams.” said Steve Yaskin, Chief Executive Office, Health Gorilla, Inc.  “The existing process is heavily dependent on paper, fax and manual processing.  It is slow, cumbersome and prone to error.  Doctors can better manage their time, and the time of their administrative and care coordinating teams, by using the power of the marketplace through the Health Gorilla app.  Now they have one place to order from any diagnostic lab, radiology center, hospital, physical therapy, sleep center, SNF and other healthcare providers in the United States.  A doctor can start with us the first day and begin ordering through the marketplace immediately.  Health Gorilla is the first to deliver this capability.  No other vendor can provide this benefit.”

Health Gorilla mobile is available as an approved Apple® enterprise application and will be distributed to existing Health Gorilla Marketplace users via a secure link for the next month.  In September Health Gorilla mobile app will be available from the Apple® store and will be fully integrated with the Apple® Health app upon its release.

About Health Gorilla
Health Gorilla™ is the first online healthcare marketplace to connect all doctors and clinicians with over 9,000+ diagnostic labs and 35,000+ radiology centers.  Doctors and their teams can instantly place orders, get results, and completely eliminate paper faxes. Uniquely, our HIPAA compliant and ONC modular certified MU2 solution is available immediately at absolutely no charge for doctors and clinicians.

Watch our 2 minute video Intro to Health Gorilla: http://youtu.be/6Luo5eNG8-s
Tweet: https://www.twitter.com/healthgorilla
Facebook: https://www.facebook.com/healthgorilla
LinkedIn: https://www.linkedin.com/company/2542523?
Sign-up for our Newsletter at the bottom of homepage:
http://www.healthgorilla.com

Contacts

For additional information contact Joe Austin via jaustin@theventanagroup.com or call 818-332-6166.

Health Gorilla™ is a trademark of Health Gorilla, Inc.
Apple®, iPhone®, iPad mini™ are trademarks of Apple, Inc.

Health Gorilla Releases Mobile Application for Doctors
Health Gorilla Releases Mobile Application for Doctors

Freya – The New Efficient App For Women Is On Kickstarter

The HedgeHog team is proud to present yet another app solution – a circular ovulation calendar that is both simple, efficient and aesthetic. Based on the popular calendar CircleTime, Freya tells you when is the best time to try to conceive or to use protection. It can also be used during pregnancy for counting the remaining time before the estimated due date.

The app, named after the Scandinavian goddess of love, sexuality, beauty and fertility – Freya offers a simple solution – without the countless irrelevant information you’ll never require. Freya’s mission is to be clear and effective.

We invite all who wish to see this app released as soon as possible, to assist the HedgeHog team with achieving their funding goal on the crowdfunding site Kickstarter. Participants have a unique opportunity to receive some genuine rewards made of natural and environmentally friendly materials. This is because sustainable development is one of the top priorities for the team and they wish to see all the natural beauty restored to the environment.

“The purpose of Freya is to provide a remarkable menstrual calendar for women which will be immensely appealing in both appearance as well as functionality”, said Sabina Durini, Freya designer and member of the HedgeHog team.

The fundraising campaign will last for 30 days and the app will initially be developed for Apple iOS devices.

Project page: https://www.kickstarter.com/projects/hedgehog-si/freya-ovulation-calendar-simple-solution-for-every
Official website: http://www.newroundcalendar.com/freya.html

Contact Details: Daniel Nunic
App Developer
Email: daniel@hedgehog.si
Phone: +38640667308

MEDIA:

PHOTO:

JPEG

Via EPR Network
More Healthcare press releases

HD Biosciences, Co., Ltd. and E. J. Corey Institute of Biomedical Research Reached Agreement for Drug R&D Collaboration

HD Biosciences Co., Ltd. (HDB) and E. J. Corey Institute of Biomedical Research (CIBR) announced that they have reached a risk-sharing agreement on collaborative drug discovery and development in the therapeutic areas of infectious diseases, metabolic diseases, and oncology. This joint effort will focus on both international and Chinese markets to provide innovative medicines for unmet healthcare needs. The agreement includes lead candidate selection pre-clinical development, IND filing, clinical trials, and NDA approvals. Both companies will share financial returns from any successes or products launches.

“We are delighted to enter this partnership. The collaboration will leverage HDB’s extensive capabilities in preclinical drug discovery and development, and create long term potentials for the company.” stated Xuehai Tan, Ph.D., President & CEO of HDB. “In combination of CIBR’s expertise in drug development, we are confident to deliver novel drug candidates over the next few years, and to make this partnership a success.”

“Working with HDB gives CIBR a unique opportunity to showcase its strength in innovative drug discovery and development,” said Wuyi Meng, Ph.D., President of CIBR. “This partnership further demonstrates CIBR’s commitment in the betterment of patient’s lives by bringing forward novel medicines. We will collaborate closely with HDB to accelerate the progress of our collaborative programs”

About HD Biosciences Co., Ltd.
HD Biosciences Co., Ltd. is a Shanghai-based, biology-focused preclinical drug discovery contract research organization (CRO). The company offers comprehensive service platforms around target validation, plate-based pharmacology, hit identification and lead discovery, therapeutic antibody discovery, in vivo pharmacology, as well as other research and development services. The company currently collaborates with eight of the ten largest pharmaceutical companies in the world and has established strategic partnerships on many key R&D areas with impacts to their portfolios. The strong scientific expertise, high quality and consistency in deliveries, constantly meeting or exceeding expectations, has earned the company a great reputation in the industry, and helped the company to build its widely recognized leadership in preclinical contract research services.http://www.hdbiosciences.com

About E. J. Corey Institute of Biomedical Research
Located in the Jiangyin High-tech Industry Development Zone in Jiangyin, Jiangsu, E. J. Corey Institute of Biomedical Research (CIBR) is a non-profit research organization founded by Nobel laureate Prof. E. J. Corey with the support from Jiangyin and Jiangsu government. CIBR is committed to scientific research in the broad biomedical field and to the development of novel therapeutics to meet the unmet medical needs of patients. In addition to its strong internal research and discovery capabilities in biomedical research and drug discovery, CIBR has established solid external capabilities in translational medicine and molecular toxicology to support drug development. Under the guidance of Nobel laureate Prof. Corey, CIBR is well poised to contribute to the discovery and development of novel medicines. http://www.cibrnobel.org

Contact Details:
HD Biosciences
Ms. Jessie Yang
Email: yangxiaojie@hdbiosciences.com

CIBR
Dr. Jiaquan Wu;
Email: jwu@cibrnobel.org

 

Via EPR Network
More Healthcare press releases

Leaky Gut Cure Through Holistic Nutrition Announced

Sufferers of leaky gut syndrome will be cheered by Karen Brimeyer’s announcement of a program called “Leaky Gut Cure” that can relieve symptoms and ease suffering from the crippling digestive track disorder. Based on healthy lifestyle recommendations, this holistic cure is based on dozens of effective ideas evolved over stringent testing and experimentation.

Nearly 2 million people have leaky gut syndrome, a poorly defined and often under-diagnosed gastro-intestinal system disorder that causes belly aches, bowel disturbance and food sensitivities. Patients often complain of abdominal cramps, bloating, flatulence and indigestion. Tired of one fad diet after another, people who have silently suffered from the condition will find this leaky gut syndrome cure the answer to a prayer.

“Obviously this system is based on extensive testing, and the author has clearly tried these methods out herself before suggesting it to others,” opined one of the early reviewers who thought the 5-point program was likely to help her. Many others who have undergone the holistic program have echoed similar sentiments.

The system called “Leaky Gut Cure” was devised by Karen Brimeyer who is a holistic nutritionist and functional medicine practitioner. It is based on a five part sequence of advice that has been shown to reverse or at least mitigate leaky gut syndrome with all her own clients. The newly packaged course takes this information out to a new audience across the world.

“The health of your gut is important in your overall health and well being” says Karen. “Leaky Gut Cure is powerful information for anyone who could be having undetected gastrointestinal disorders resembling the syndrome.”

Many effective treatments and lifestyle changes are revealed in this guide, including 3 health foods that are widely recommended and consumed by millions of people daily, but that could make the symptoms of leaky gut syndrome worse. Considering how beneficial it is to sufferers, the program is affordable and widely accessible. Victims of leaky gut can get the information without wasting hundreds, or even thousands of dollars on expensive doctor visits or costly tests to detect and monitor disease progress.

Karen Brimeyer is giving away a free report that shares three effective techniques for leaky gut cure from her website. For more information about the Leaky Gut Cure go to http://www.LeakyGutCureReview.org

Contact Details: LeakyGutCureReview.org
Optibiz Publishing, P.O.Box 90012,
Chennai, TN 600107
info@LeakyGutCureReview.org
http://www.LeakyGutCureReview.org

Via EPR Network
More Healthcare press releases

EMS Healthcare receives ISO accreditation for fourth consecutive year

EMS Healthcare has announced that it has achieved ISO accreditation for the fourth consecutive year.

It is the latest in a long line of endorsements that the UK event marketing organisation has achieved continuously and maintained over the years. It marks EMS Healthcare as a first-class employer.

By investing in standards of best practice, EMS Healthcare not only gives their customers peace of mind and the confidence to do business with them, but they are also able to recruit the best and brightest talent in the event trailer hire and mobile medical accommodation industry.

Ultimately, it strengthens our proposition to both existing clients and prospects; whilst also helping to strengthen their ongoing recruitment drive. Ultimately it makes good business sense all round.

David Legg, Finance Director at EMS said: “We may be a SME business, but we are perfectly formed and certainly have big company values.

“When it comes to our staff, this is no exception, and we’re delighted to have recently passed the BS OHSAS 18001:2007 – Occupational Health and Safety Standard, which is no mean feat.

“It’s the fourth consecutive year that we have achieved the accreditation. And we were among one of the first live events companies to lead the way in its attainment.”

Find out more about EMS Healthcare and mobile medical accomodation today by calling 0151 350 1500 or visiting http://ems-healthcare.com.

Via EPR Network
More Healthcare press releases

Providing Personalized Service to Clients in Need of Health Insurance Solutions

Loyal Leaf™ is in the business of providing tailored, personalized service to clients in need of health insurance solutions. They take pride in being insurance guides who provide one-stop, last-stop service by offering a complete range of products and professional service.

Their newly designed website has been reinvented in order to serve their client base better by providing a comprehensive assortment of insurance packages under one roof. It is designed to provide information, tools and education to those in search of health insurance. With an easy interface and improved navigation Loyal Leaf has created a naturally comfortable environment for the consumer. It is vital in the ever changing world of the health care industry that all information be current and viable and clearly stated. Loyal Leaf through its brand new website is doing its part to demonstrate their professionalism with their improved online presence. The inclusion of an information filled health-related blog rounds out the presentation.

Loyal Leaf’s insurance agents continue to have an advanced toolbox with which to compare both prices and products from a wide selection of top tier insurance carriers. They are very well versed on the latest Obama Care regulations and the advent of new and exciting product options for their client offerings.

Via EPR Network
More Healthcare press releases

The End of Alzheimer’s? A revolutionary scientific advance to the cure

Interface Dynamics Control Corporation (IDCC) has completed the first phase of its decade-long Advanced Therapeutic Interventions Project, with the result that a new approach to arresting and curing Alzheimer’s disease and the other neurodegenerative diseases has been produced and verified. IDCC is now launching the Project’s second phase, which will validate the first phase findings.

Alzheimer’s disease is the sixth leading cause of death in the United States, with more than 5.1 million Americans currently affected. The direct cost of Alzheimer’s is greater than $200 billion annually, a number expected reach between $1.2 and $1.5 trillion by 2050. Indirect costs are substantial: more than 15 million caregivers delivered some 17.5 billion hours of unpaid care valued at more than $200 billion.

IDCC has discovered the mechanism of and means to control the protein misfolding, abnormal aggregation, and degradation processes associated with the degenerative and prion diseases. That mechanism is also implicated in the failure to clear toxic intracellular proteins and in the dysfunction of apoptotic (programmed cell death) pathways. It underlies the adverse functions of the neuroglia (glial cells), including microglia, which provide immune defense to the central nervous system (CNS) and maintain homeostasis and protection for neurons in the brain and the peripheral nervous system.

The process of neurodegeneration has not been understood previously, which has precluded the production of any arresting or curative procedures or drugs. The Project’s findings, however, should lead to the realization of a new class of curative procedures and pharmaceuticals which can be engaged to defeat the disease-initiating neurodegenerative insult, thereby introducing the possibility of preventing these devastating diseases. There are direct implications for the human cancers, but verification of those implications must await further experiments.

The first major activity under the Project’s second phase will be the production of a new class of active imaging system. That system will be utilized to demonstrate the activities and accessible control points of the process pathways which, when certain abnormal events occur, trigger the incipient causal mechanisms of disease. The Project is currently developing the staff and capitalization required for execution of its second phase.

About IDCC 
IDCC was founded thirteen years ago to produce definitive solutions to seemingly intractable problems of social and technological significance. It is privately held and maintains its projects and client identities in strict confidence unless and until information releases are authorized by competent authority.

Contact Details: Peter W. Atkinson
IDCC
4655 Logsdon Drive
Annandale, VA 22003-3564 USA
+1.703.879.7065
Peter@InterfaceDynamicsControl.com

Via EPR Network
More Healthcare press releases

Largest Temporary Renal Dialysis Unit Deployed at King’s College Hospital

A temporary renal dialysis unit at King’s College Hospital NHS Foundation Trust has been increased in size to maximise efficiency, enabling the treatment of a greater number of patients.

The Liberty Quad unit,which links four 13.6m medical trailers together, has been providing essential care to hundreds of patients at the Trust’s Dulwich Community Hospital site since it was installed by EMS-Healthcare in February last year.

Initially intended as a six-month temporary solution, its success has led to the contract being extended until 2015 as well as its capacity increased.

The addition of a fifth mobile medical trailerhas created an eight-bed ward,plus a dedicated recovery bay and spacious, clean utility storage as well as a large comfortable working station for nursing staff. It is the largest single unit healthcare facility to be deployed by EMS-Healthcare.

Keith Austin, CEO in EMS-Healthcare said: “We took on board the Trust’s feedback and made significant improvements to the unit to help maximise efficiency and provide a more comfortable and spacious workplace for nurses to treat their patients.

“A major benefit of the Liberty Quad Plus facility is that it can be deployed quickly and efficiently as there is no structure to build or major site preparation required. The fifth unit was simply driven onto site and all fit out changes made over a weekend to ensure minimal impact on patient service.”

The temporary renal dialysis unit provides the ultimate flexible solution to estate management and clinical teams, ensuring King’s College Hospital NHS Foundation Trust can continue to provide high levels of life-saving care. The facility is operational six days a week delivering three sessions per day to groups of eight patients at a time.

Via EPR Network
More Healthcare press releases

BlueFire Marketing Announces Launch of New Healthcare Reminder Service

BlueFire Marketing, a fully integrated marketing firm, announced today the launch of a text message marketing reminder service for healthcare providers. This service allows them to automatically remind patients of upcoming appointments. This reduces time and cost for healthcare providers who manually and individually call patients to remind them of their appointments.

BlueFire Marketing recognizes changing trends in both the market and in consumer preferences. In the U.S., smartphone penetration has reached 54%, and is projected to hit 84% by 2016. This creates an opportunity to reach individuals and build 1-on-1 relationships at an incredibly low cost.

Curt Johnson, President of BlueFire Marketing, said, “The beauty of the smartphone era for retailers and healthcare professionals is that the cost of the marketing medium is paid for by the consumer. The more your marketing mix shifts towards digital, the lower your cost per thousand.”

Via EPR Network
More Healthcare press releases

Healthcare Outcomes Solutions Launches Patient Centered Enhanced Care Model to Reduce Healthcare Costs for Chronically Ill Patients of Self insured companies and improve their care

Healthcare Outcomes Solutions (HOS), a company dedicated to reducing health care costs for self insured companies and their employees, recently launched its Patient Centered Enhanced Care model (PCEC). PCEC is a care coordination model designed to improve health care and reduce costs specifically for employee-patients, or their family members, with multiple chronic illnesses who are in a health plan offered by self-funded companies.

It is now common knowledge that approximately 5% of members of health plans account for about 50% of the cost. Multiple chronic diseases are the source of the majority of the cost in healthcare. The PCEC model enables self-funded businesses across the U.S. to offer coordinated care specifically for these member-patients. This service is offered to middle size or larger employers.

The PCEC model has been developed by healthcare experts and is grounded in extensive research of evidence-based and outcomes studies, many of which are available on the HOS website, www.healthcareoutcomes.net. The latest data on healthcare costs show that care coordination of the most chronically ill member-patients can reduce a company’s healthcare costs significantly.

We will work with companies to determine if the PCEC model is right for them. Affiliated healthcare accountants will examine a company’s current health care expenses, and HOS will determine the feasibility of reducing cost while improving care.

Via EPR Network
More Healthcare press releases